Document AMR & HAIS

MedTech Europe’s statement on European Antibiotic Awareness Day 2020

Antimicrobial Resistance (AMR) is a major global health concern that puts in jeopardy the effective prevention and treatment of an ever-increasing range of infections as well as modern medicine. The good news is that tools and solutions to tackle AMR and Healthcare-Associated Infections (HAIs) are already available to support patient care throughout the patient pathway.

Since 2016, MedTech Europe has been working increasingly with multiple partners and our own network of national associations to contribute to the ongoing discussions at EU level regarding the prevention and tackling of AMR and HAIs. To this end, we have recently published a position paper on the role of medical technologies in the fight against antimicrobial resistance and healthcare association infections (see our position paper).

MedTech Europe believes that coordinated efforts by all relevant stakeholders are crucial in the fight against AMR and HAIs. We remain committed to continue working without silos with stakeholders from both the public and private sector, and the civil society to tackle this health challenge. Therefore, we participate in the AMR Stakeholder Network under the auspices of the European Commission’s Health Policy Platform and we also engage as a stakeholder in the EU Joint Action on AMR and HAIs, a coordinated European initiative to develop and implement effective One Health policies.

MedTech Europe will continue working closely with its members and partners so that the fight against AMR and HAIs remains a political priority for the European Institutions as well as Member States in the ‘new normal’.

Posted on 18.11.2020

Related content